Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06408688
Title Safety and Modulation of Adaptive Immunity by Iscador Qu Viscum Album Extract in Patients With Advanced, Recurrent or Metastatic Cancers Treated With Immune Checkpoint Inhibitors (ISCA-CHECK)
Acronym ISCA-CHECK
Recruitment Not yet recruiting
Gender both
Phase FDA approved
Variant Requirements No
Sponsors University Hospital, Basel, Switzerland
Indications
Therapies
Age Groups: adult | senior
Covered Countries CHE


No variant requirements are available.